Skip to content

Diagnosis of Superficial Lymphadenopathy

SMI and CEUS in the Diagnosis of Superficial Lymphadenopathy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04928560
Enrollment
500
Registered
2021-06-16
Start date
2020-09-01
Completion date
2022-12-30
Last updated
2021-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphadenopathy, ULTRASOUND

Brief summary

The purpose of this study is to study the application of CEUS and SMI technology in superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Detailed description

CEUS and SMI technology were used to evaluated the superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Interventions

DIAGNOSTIC_TESTSMI

ULTRASOUND

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years old and ≤ 80 years old; 2. Patients with enlarged lymph nodes detected by ultrasound; 3. No contraindications such as hypersensitivity to contrast-enhanced ultrasound; 4. Voluntarily enrolled in this research project

Exclusion criteria

* The patient's position cannot be matched during ultrasound examination * Treatment history of lesion area: operation, radiotherapy, intervention, etc ③ Patients without informed consent ④ Lack of clinical data (no effective images such as two-dimensional ultrasound, color Doppler, contrast-enhanced ultrasound, micro blood flow imaging, or poor image quality, unable to analyze, unknown pathological results, etc.) ⑤ Lack of follow up information

Design outcomes

Primary

MeasureTime frameDescription
PATHOLOGYup to 3 monthsBIOPSY/SURGERY

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026